Clinical trials
Myelodysplastic Syndromes trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
| Completed | 4 |
| Recruiting | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 3 |
| Haukeland University Hospital | 2 |
| BerGenBio ASA | 1 |
| Bristol-Myers Squibb | 1 |
| Cellphire Therapeutics, Inc. | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Gilead Sciences | 1 |
| Nordic MDS Group | 1 |
| Novartis Pharmaceuticals | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 13 |
| Leukemia, Myeloid, Acute | 4 |
| Leukemia | 2 |
| Thrombocytopenia | 2 |
| Anemia | 1 |
| Anemia, Aplastic | 1 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Hematologic Neoplasms | 1 |
| Hemochromatosis | 1 |
| Iron Overload | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.